Citius Pharmaceuticals (CTXR) EPS (Diluted) (2010 - 2026)
Powered by 
Analysis
Citius Pharmaceuticals (CTXR) EPS (Diluted) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.84 Bn | 626.09 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 449.07 Bn | 442.50 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 362.31 Bn | 355.17 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 268.33 Bn | 260.64 Bn | 11.24 Bn | 1.67 |
| 5 | Pfizer | 157.40 Bn | 145.70 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 52.36 Bn | 44.97 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 43.21 Bn | 43.21 Bn | - | -3.06 |
| 8 | Incyte | 25.31 Bn | 20.77 Bn | 1.57 Bn | 2.81 |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | 7.27 |
| 10 | Citius Pharmaceuticals | 15.33 Mn | 15.33 Mn | 1.00 Mn | -0.34 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.34 |
| Mar 31, 2026 | -0.95 |
| Dec 31, 2025 | -0.38 |
| Sep 30, 2025 | -0.72 |
| Jun 30, 2025 | -0.80 |
| Mar 31, 2025 | -1.27 |
| Dec 31, 2024 | -1.30 |
| Sep 30, 2024 | -1.71 |
| Jun 30, 2024 | -0.06 |
| Mar 31, 2024 | -0.05 |
| Dec 31, 2023 | -0.06 |
| Sep 30, 2023 | -0.07 |
| Jun 30, 2023 | -0.06 |
| Mar 31, 2023 | -0.07 |
| Dec 31, 2022 | -0.02 |
| Sep 30, 2022 | -0.05 |
| Jun 30, 2022 | -0.06 |
| Mar 31, 2022 | -0.05 |
| Dec 31, 2021 | -0.06 |
| Sep 30, 2021 | -0.05 |